Which has better valuation and earnings, WAY or DOCS?

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.65 $112.09M $0.70 38.10 Doximity $644.86M 7.12 $196.05M $0.85 30.29

Is WAY or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Doximity 25.48% 18.06% 15.40%

Does the media refer more to WAY or DOCS?

In the previous week, Waystar had 17 more articles in the media than Doximity. MarketBeat recorded 24 mentions for Waystar and 7 mentions for Doximity. Doximity's average media sentiment score of 0.85 beat Waystar's score of 0.63 indicating that Doximity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 11 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, HTFL or DOCS?

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 23.87 -$116.79M -$1.83 N/A Doximity $644.86M 7.12 $196.05M $0.85 30.29

Is HTFL or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Doximity 25.48% 18.06% 15.40%

Does the media prefer HTFL or DOCS?

In the previous week, Heartflow had 22 more articles in the media than Doximity. MarketBeat recorded 29 mentions for Heartflow and 7 mentions for Doximity. Doximity's average media sentiment score of 0.85 beat Heartflow's score of 0.56 indicating that Doximity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 11 Very Positive mention(s) 6 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, DOCS or SDGR?

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 7.12 $196.05M $0.85 30.29 Schrodinger $255.87M 6.71 -$103.26M -$0.74 N/A

Is DOCS or SDGR more profitable?

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Schrodinger -20.98% -16.37% -8.19%

Does the media refer more to DOCS or SDGR?

In the previous week, Schrodinger had 1 more articles in the media than Doximity. MarketBeat recorded 8 mentions for Schrodinger and 7 mentions for Doximity. Doximity's average media sentiment score of 0.85 beat Schrodinger's score of 0.58 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, DOCS or GDRX?

Doximity has higher earnings, but lower revenue than GoodRx. Doximity is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 7.12 $196.05M $0.85 30.29 GoodRx $796.85M 1.50 $30.44M $0.04 87.25

Is DOCS or GDRX more profitable?

Doximity has a net margin of 25.48% compared to GoodRx's net margin of 2.07%. Doximity's return on equity of 18.06% beat GoodRx's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% GoodRx 2.07% 7.22% 2.53%

Which has higher earnings & valuation, CERT or DOCS?

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.06 -$1.60M -$0.45 N/A Doximity $644.86M 7.12 $196.05M $0.85 30.29

Is CERT or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Doximity 25.48% 18.06% 15.40%

Does the media refer more to CERT or DOCS?

In the previous week, Doximity had 5 more articles in the media than Certara. MarketBeat recorded 7 mentions for Doximity and 2 mentions for Certara. Doximity's average media sentiment score of 0.85 beat Certara's score of 0.74 indicating that Doximity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Doximity (DOCS) Competitors

$25.75 -0.64 (-2.44%)

Closing price 09/15/2026 03:59 PM Eastern

Extended Trading

$25.79 +0.04 (+0.17%)

As of 09/15/2026 07:30 PM Eastern

Compare

DOCS vs. WAY, HTFL, SDGR, GDRX, and CERT

Should you buy Doximity stock or one of its competitors? Doximity's main competitors and comparable companies include Waystar (WAY), Heartflow (HTFL), Schrodinger (SDGR), GoodRx (GDRX), and Certara (CERT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Doximity compare to Waystar?

Waystar (NASDAQ:WAY) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Doximity	25.48%	18.06%	15.40%

Waystar presently has a consensus target price of $35.27, suggesting a potential upside of 32.26%. Doximity has a consensus target price of $32.18, suggesting a potential upside of 25.00%. Given Waystar's stronger consensus rating and higher possible upside, equities research analysts plainly believe Waystar is more favorable than Doximity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.92
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.31

In the previous week, Waystar had 17 more articles in the media than Doximity. MarketBeat recorded 24 mentions for Waystar and 7 mentions for Doximity. Doximity's average media sentiment score of 0.85 beat Waystar's score of 0.63 indicating that Doximity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	11 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market. Comparatively, Doximity has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market.

87.2% of Doximity shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 31.8% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.65	$112.09M	$0.70	38.10
Doximity	$644.86M	7.12	$196.05M	$0.85	30.29

Summary

Doximity beats Waystar on 10 of the 16 factors compared between the two stocks.

How does Doximity compare to Heartflow?

Heartflow (NASDAQ:HTFL) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

Heartflow presently has a consensus price target of $44.88, indicating a potential downside of 7.15%. Doximity has a consensus price target of $32.18, indicating a potential upside of 25.00%. Given Doximity's higher probable upside, analysts plainly believe Doximity is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.31

In the previous week, Heartflow had 22 more articles in the media than Doximity. MarketBeat recorded 29 mentions for Heartflow and 7 mentions for Doximity. Doximity's average media sentiment score of 0.85 beat Heartflow's score of 0.56 indicating that Doximity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	11 Very Positive mention(s)	6 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

87.2% of Doximity shares are owned by institutional investors. 7.7% of Heartflow shares are owned by company insiders. Comparatively, 31.8% of Doximity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	23.87	-$116.79M	-$1.83	N/A
Doximity	$644.86M	7.12	$196.05M	$0.85	30.29

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Doximity	25.48%	18.06%	15.40%

Summary

Doximity beats Heartflow on 12 of the 16 factors compared between the two stocks.

How does Doximity compare to Schrodinger?

Doximity (NYSE:DOCS) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Schrodinger	-20.98%	-16.37%	-8.19%

In the previous week, Schrodinger had 1 more articles in the media than Doximity. MarketBeat recorded 8 mentions for Schrodinger and 7 mentions for Doximity. Doximity's average media sentiment score of 0.85 beat Schrodinger's score of 0.58 indicating that Doximity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	7.12	$196.05M	$0.85	30.29
Schrodinger	$255.87M	6.71	-$103.26M	-$0.74	N/A

Doximity currently has a consensus price target of $32.18, suggesting a potential upside of 25.00%. Schrodinger has a consensus price target of $20.50, suggesting a potential downside of 11.83%. Given Doximity's stronger consensus rating and higher possible upside, research analysts plainly believe Doximity is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.31
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

87.2% of Doximity shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 31.8% of Doximity shares are owned by insiders. Comparatively, 10.1% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Doximity has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market.

Summary

Doximity beats Schrodinger on 15 of the 17 factors compared between the two stocks.

How does Doximity compare to GoodRx?

Doximity (NYSE:DOCS) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Doximity currently has a consensus price target of $32.18, suggesting a potential upside of 25.00%. GoodRx has a consensus price target of $4.23, suggesting a potential upside of 21.13%. Given Doximity's stronger consensus rating and higher probable upside, analysts clearly believe Doximity is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.31
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

Doximity has higher earnings, but lower revenue than GoodRx. Doximity is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	7.12	$196.05M	$0.85	30.29
GoodRx	$796.85M	1.50	$30.44M	$0.04	87.25

In the previous week, Doximity had 6 more articles in the media than GoodRx. MarketBeat recorded 7 mentions for Doximity and 1 mentions for GoodRx. GoodRx's average media sentiment score of 1.08 beat Doximity's score of 0.85 indicating that GoodRx is being referred to more favorably in the news media.

Company	Overall Sentiment
Doximity	Positive
GoodRx	Positive

87.2% of Doximity shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 31.8% of Doximity shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Doximity has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.59, indicating that its stock price is 59% more volatile than the broader market.

Doximity has a net margin of 25.48% compared to GoodRx's net margin of 2.07%. Doximity's return on equity of 18.06% beat GoodRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
GoodRx	2.07%	7.22%	2.53%

Summary

Doximity beats GoodRx on 13 of the 17 factors compared between the two stocks.

How does Doximity compare to Certara?

Certara (NASDAQ:CERT) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Certara currently has a consensus price target of $8.28, suggesting a potential downside of 1.46%. Doximity has a consensus price target of $32.18, suggesting a potential upside of 25.00%. Given Doximity's higher probable upside, analysts clearly believe Doximity is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.31

74.0% of Certara shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 1.1% of Certara shares are owned by insiders. Comparatively, 31.8% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Doximity	25.48%	18.06%	15.40%

Certara has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, Doximity has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market.

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.06	-$1.60M	-$0.45	N/A
Doximity	$644.86M	7.12	$196.05M	$0.85	30.29

In the previous week, Doximity had 5 more articles in the media than Certara. MarketBeat recorded 7 mentions for Doximity and 2 mentions for Certara. Doximity's average media sentiment score of 0.85 beat Certara's score of 0.74 indicating that Doximity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Doximity beats Certara on 15 of the 17 factors compared between the two stocks.

Get Doximity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOCS vs. The Competition

Export

Metric	Doximity	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$4.70B	$1.72B	$7.21B	$23.26B
Dividend Yield	N/A	4.68%	2.57%	3.58%
P/E Ratio	30.29	20.40	272.84	28.40
Price / Sales	7.12	91.36	701.69	20.31
Price / Cash	21.29	31.75	77.71	34.34
Price / Book	4.96	6.21	10.37	4.69
Net Income	$196.05M	-$18.66M	$3.49B	$1.07B
7 Day Performance	6.46%	1.92%	-0.76%	-1.48%
1 Month Performance	3.56%	1.99%	-0.39%	-4.27%
1 Year Performance	N/A	-14.10%	18.93%	8.97%

Doximity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOCS Doximity	4.6989 of 5 stars	$25.75 -2.4%	$32.18 +25.0%	N/A	$4.70B	$644.86M	30.29	880	Analyst Upgrade
WAY Waystar	4.4914 of 5 stars	$23.47 flat	$35.14 +49.7%	-29.8%	$4.50B	$1.10B	33.53	1,700	Trending News Analyst Forecast Gap Up
HTFL Heartflow	2.0174 of 5 stars	$49.88 flat	$44.88 -10.0%	+46.9%	$4.34B	$176.03M	N/A	843	Trending News Insider Trade
SDGR Schrodinger	0.8404 of 5 stars	$19.02 flat	$20.50 +7.8%	+25.9%	$1.40B	$255.87M	N/A	850
GDRX GoodRx	4.4638 of 5 stars	$3.39 flat	$4.23 +24.7%	-14.5%	$1.16B	$796.85M	84.77	697	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DOCS) was last updated on 9/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Doximity (DOCS) Competitors